Mechanistic studies investigating biological factors linking obesity and carcinogenesis, and in particular the role of IGF-1R signaling in the development of tumors in the context of obesity, may reveal populations at risk for obesity-driven tumorigenesis, as well as potential therapeutic targets for cancer therapy. This evidence concerns the gene IGF1R and cancer.